Serotonin (5-HT) is one of the most extensively studied neurotransmitters of the central nervous system. 5-HT is, however, also present in a variety of peripheral tissues including in constituents of the immune system. The function of 5-HT in the immune system has received increasing attention since about 1984, but has been reviewed only once, in 1985. In recent years, modern techniques of molecular biology such as reverse-transcriptase polymerase chain reaction and targeted gene disruption have made it possible to study new important aspects of 5-HT in the immune system. In the first part of the review, we explore whether 5-HT is involved in interactions between the central nervous and immune systems. It emerges that 5-HT may mediate interactions of these two systems by four different pathways. In the second part, we dissect the functional roles of 5-HT in the immune system. We describe the distribution of 5-HT receptors and the 5-HT transporter on immune cells and estimate which levels 5-HT may attain in the extracellular space in physiological conditions and under pathological circumstances such as inflammation, thrombosis, and ischemia. At these 5-HT concentrations, four major functions for 5-HT emerge. These include T cell and natural killer cell activation, delayed-type hypersensitivity responses, production of chemotactic factors, and natural immunity delivered by macrophages. Finally, we discuss promising future avenues to further advance knowledge of the role of 5-HT in the immune system and in neuroimmune interactions.
INTRODUCTION
Compared to the immense body of work elucidating the role of 5-HT as a neurotransmitter of the central nervous system, the functional role of 5-HT in the immune system has been investigated much less. Slauson and co-workers noted in 1984: ''There has been surprisingly little attention given to the effects of serotonin on lymphocyte populations, although its effect as an inflammatory mediator on smooth muscle of the respiratory and cardiovascular systems, and its functions as a chemical transmitter in neurons in the brain are well documented.'' Serotonin-like activity was first found in 1868, with defibrinated blood increasing vascular resistance of perfused muscle (cited in Page, 1978) . Enteramine, thought to originate from enterochromaffin cells, was named in 1933 by Vialle and Erspamer and isolated from the gastrointestinal tract in 1940 (Erspamer, 1940) . In 1948, serotonin was named as a serum component tonicizing smooth muscle and was isolated and identified as 5-hydroxytryptamine (Rapport, Green, & Page, 1948; Rapport, 1949) . In 1952, enteramine was found to be identical to 5-HT (Erspamer & Asero, 1952) , and in 1953 5-HT was found in the brain by Twarog and Page. In the five-volume monograph ''Serotonin in Health and Disease'' (Essmann, 1978a) , no section is dedicated to the role of 5-HT in the immune system. This topic has been reviewed only once, in 1985 by Roszman and co-workers.
